文献速递儿童青少年精神

智力障碍与非智力障碍儿童青少年抗精神病药与抗抑郁药处方记录关联研究

Antipsychotic and antidepressant prescribing for 704 297 children and young people with and without intellectual disabilities: record linkage study.
PubMed 文献 · Br J Psychiatry · 2021-01-01

研究将苏格兰年度学生普查与处方信息系统记录关联,分析704 297名儿童青少年中抗精神病药与抗抑郁药处方情况。结果显示智力障碍学生使用抗精神病药(1.74% vs 0.12%,调整OR=16.85)和抗抑郁药(1.18% vs 0.66%,调整OR=2.28)的比例显著更高,且两类药物处方随时间增加,但智力障碍与非智力障碍学生之间的处方差异逐年缩小。

要点

  • 智力障碍学生抗精神病药处方调整OR为16.85(95%CI 15.29-18.56),显著高于非智力障碍学生。
  • 智力障碍学生抗抑郁药处方调整OR为2.28(95%CI 2.03-2.56),差异逐年减小。
  • 两类药物处方总体随时间增加,但智力障碍学生增幅较小,提示治疗进展不均衡或既往过度处方在改变。

核心结论

  • 智力障碍儿童青少年抗精神病药和抗抑郁药处方比例显著高于非智力障碍同龄人。
  • 处方总体随时间增加,但智力障碍学生与非智力障碍学生之间的处方差异逐年缩小。

研究设计与样本

  • 记录关联研究,将苏格兰年度学生普查与处方信息系统关联,纳入704 297名儿童青少年,其中16 142名(2.29%)有智力障碍记录。
  • 采用逻辑回归分析2010至2013年抗精神病药和抗抑郁药处方情况。

主要发现

  • 抗精神病药处方:智力障碍学生281名(1.74%),非智力障碍学生802名(0.12%),调整OR=16.85(95%CI 15.29-18.56)。
  • 抗抑郁药处方:智力障碍学生191名(1.18%),非智力障碍学生4561名(0.66%),调整OR=2.28(95%CI 2.03-2.56)。
  • 抗精神病药使用在男生中更高,抗抑郁药使用在女生中更高,且均随年龄增长而增加。
  • 智力障碍学生抗精神病药调整OR从2010年20.19降至2013年14.24,抗抑郁药调整OR从3.10降至2.02。

关键数值与推荐

  • 抗精神病药总体调整OR=16.85(95%CI 15.29-18.56),2010年调整OR=20.19,2013年调整OR=14.24。
  • 抗抑郁药总体调整OR=2.28(95%CI 2.03-2.56),2010年调整OR=3.10,2013年调整OR=2.02。

临床怎么用

  • 临床关注智力障碍儿童青少年抗精神病药与抗抑郁药处方,警惕潜在过度处方。
  • 注意智力障碍学生处方增幅较小,可能反映治疗进展不均衡,需评估其是否获得同等治疗机会。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psychotropics are overprescribed for adults with intellectual disabilities; there are few studies in children and young people. AIMS: To investigate antipsychotic and antidepressant prescribing in children and young people with and without intellectual disabilities, and prescribing trends. METHOD: Scotland's annual Pupil Census, which identifies pupils with and without intellectual disabilities, was record-linked to the Prescribing Information System. Antidepressant and antipsychotic data were extracted. Logistic regression was used to analyse prescribing between 2010 and 2013. RESULTS: Of the 704 297 pupils, 16 142 (2.29%) had a record of intellectual disabilities. Antipsychotic and antidepressant use increased over time, and was higher in older pupils; antipsychotic use was higher in boys, and antidepressant use was higher in girls. Overall, antipsychotics were prescribed to 281 (1.74%) pupils with intellectual disabilities and 802 (0.12%) without (adjusted odds ratio 16.85, 95% CI 15.29-18.56). The higher use among those with intellectual disabilities fell each year (adjusted odds ratio 20.19 in 2010 v. 14.24 in 2013). Overall, 191 (1.18%) pupils with intellectual disabilities and 4561 (0.66%) without were prescribed antidepressants (adjusted odds ratio 2.28, 95% CI 2.03-2.56). The difference decreased each year (adjusted odds ratio 3.10 in 2010 v. 2.02 in 2013). CONCLUSIONS: Significantly more pupils with intellectual disabilities are prescribed antipsychotics and antidepressants than are other pupils. Prescribing overall increased over time, but less so for pupils with intellectual disabilities; either they are not receiving the same treatment advances as other pupils, or possible overprescribing in the past is changing. More longitudinal data are required.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Henderson A, Kinnear D, Fleming M, et al. Antipsychotic and antidepressant prescribing for 704 297 children and young people with and without intellectual disabilities: record linkage study. Br J Psychiatry. 2021. PMID: 33541472. doi:10.1192/bjp.2020.232

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。